Trial intelligence / Profile preview

Prophylactic fresh frozen plasma versus no plasma before invasive ICU procedures

NL-OMON38043Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of fresh-frozen plasma in coagulopathy (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Procedure-related relevant bleeding within 24 hours. Started May 2010; status: active, not recruiting.

02

Drugs

fresh-frozen plasma
03

Conditions

coagulopathy

Beyond the preview

Go deeper on NL-OMON38043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call